Square Pharmaceuticals Overview
- Year Founded
-
1958
- Status
-
Public
- Employees
-
12,453
- Stock Symbol
-
SQURPHARMA
- Share Price
-
$1.69
- (As of Thursday Closing)
Square Pharmaceuticals General Information
Description
Square Pharmaceuticals PLC is a Bangladesh-based pharmaceutical company engaged in the manufacturing and marketing of generic pharmaceuticals products, Basic chemical products, and animal health products. The company operates in one segment, which is the business of developing, manufacturing, and marketing drugs for health care for all living species. It manufactures drugs like paracetamol, clotrimazole, antiallergic, Nitroglycerin, xylometazoline HCl, erythromycin, and various other drugs. Company also provides devices such as AnsuPen and AnsuPen Twist. The company operates in Bangladesh and sells its products locally and internationally.
Contact Information
Website
www.squarepharma.com.bdCorporate Office
- Square Centre, 48
- Mohakhali Commercial Area
- Dhaka, 1212
- Bangladesh
Corporate Office
- Square Centre, 48
- Mohakhali Commercial Area
- Dhaka, 1212
- Bangladesh
Square Pharmaceuticals Stock Performance
As of 15-May-2025, Square Pharmaceuticals’s stock price is $1.69. Its current market cap is $1.5B with 886M shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $1.69 | $1.70 | $1.66 - $2.06 | $1.5B | 886M | 279K | $0.22 |
Square Pharmaceuticals Financials Summary
As of 31-Mar-2025, Square Pharmaceuticals has a trailing 12-month revenue of $632M.
|
In Thousands, USD |
TTM 31-Mar-2025 | FY 2024 30-Jun-2024 | FY 2023 30-Jun-2023 | FY 2022 30-Jun-2022 |
|---|---|---|---|---|
| EV | 1,220,191 | 1,165,153 | 1,248,592 | 1,493,027 |
| Revenue | 631,971 | 623,462 | 580,759 | 655,056 |
| EBITDA | 180,446 | 187,811 | 191,220 | 225,151 |
| Net Income | 195,800 | 186,109 | 181,570 | 206,500 |
| Total Assets | 1,162,045 | 1,112,795 | 1,109,313 | 1,175,046 |
| Total Debt | 8,021 | 11,990 | 18,094 | 20,127 |
Square Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Square Pharmaceuticals Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Square Pharmaceuticals ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
Square Pharmaceuticals FAQs
-
When was Square Pharmaceuticals founded?
Square Pharmaceuticals was founded in 1958.
-
Where is Square Pharmaceuticals headquartered?
Square Pharmaceuticals is headquartered in Dhaka, Bangladesh.
-
What is the size of Square Pharmaceuticals?
Square Pharmaceuticals has 12,453 total employees.
-
What industry is Square Pharmaceuticals in?
Square Pharmaceuticals’s primary industry is Pharmaceuticals.
-
Is Square Pharmaceuticals a private or public company?
Square Pharmaceuticals is a Public company.
-
What is Square Pharmaceuticals’s stock symbol?
The ticker symbol for Square Pharmaceuticals is SQURPHARMA.
-
What is the current stock price of Square Pharmaceuticals?
As of 15-May-2025 the stock price of Square Pharmaceuticals is $1.69.
-
What is the current market cap of Square Pharmaceuticals?
The current market capitalization of Square Pharmaceuticals is $1.5B.
-
What is Square Pharmaceuticals’s current revenue?
The trailing twelve month revenue for Square Pharmaceuticals is $632M.
-
What is Square Pharmaceuticals’s annual earnings per share (EPS)?
Square Pharmaceuticals’s EPS for 12 months was $0.22.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
